-
公开(公告)号:US20050147610A1
公开(公告)日:2005-07-07
申请号:US10988360
申请日:2004-11-12
申请人: Tariq Ghayur , Boris Labkovsky , Jeffrey Voss , Larry Green , John Babcook , Xiao-chi Jia , James Wieler , Jaspal Kang , Brad Hedberg
发明人: Tariq Ghayur , Boris Labkovsky , Jeffrey Voss , Larry Green , John Babcook , Xiao-chi Jia , James Wieler , Jaspal Kang , Brad Hedberg
IPC分类号: A61K39/395 , C07H21/04 , C07K16/24 , C12N5/06 , C12P21/04
CPC分类号: C07K16/244 , A61K2039/505 , C07H21/04 , C07K2317/21
摘要: The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental.
摘要翻译: 本发明包括IL-18结合蛋白,特别是结合人白细胞介素-18(hIL-18)的抗体。 具体地,本发明涉及完全是人抗体的抗体。 优选的抗体对hIL-18具有高亲和力和/或在体外和体内中和hIL-18活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 还提供了制备方法和使用本发明抗体的方法。 本发明的抗体或抗体部分可用于检测hIL-18和抑制hIL-18活性,例如在患有hIL-18活性有害的病症的人类受试者中。
-
公开(公告)号:US20050100965A1
公开(公告)日:2005-05-12
申请号:US10706689
申请日:2003-11-12
申请人: Tariq Ghayur , Boris Labkovsky , Jeffrey Voss , Larry Green , John Babcook , Xiao-chi Jia , James Wieler , Jaspal Kang , Brad Hedberg
发明人: Tariq Ghayur , Boris Labkovsky , Jeffrey Voss , Larry Green , John Babcook , Xiao-chi Jia , James Wieler , Jaspal Kang , Brad Hedberg
CPC分类号: G01N33/6869 , A61K2039/505 , C07K16/244 , C07K2317/33 , C07K2317/52 , C07K2317/55 , C07K2317/71 , C07K2317/76 , C07K2317/92 , C07K2317/94 , Y02A50/407
摘要: The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental.
-